Background: A combination of morphological and functional imaging plays a crucial role for neuroendocrine tumors (NETs) management. Diffusion-weighted magnetic resonance imaging (DWI-MRI) is an emerging key imaging technique in the NET field. Aim: to evaluate the diagnostic and prognostic role of DWI-MRI in liver metastases (LMs) from NETs compared with multiparametric MRI and functional imaging with 68Ga-DOTA peptides positron emission tomography (PET)-computed tomography (CT). Methods: This is a monocentric, observational, both retrospective and prospective study including patients with histologically proven diagnosis of gastroenteropancreatic (GEP) NET with LM evaluated with MRI and 68Ga-DOTA peptides PET-CT, performed within 6 months apart at diagnosis or follow-up. We collected clinical, pathological, imaging data including lesions number detected on (a)MRI-gold standard, (b)DWI images, (c)68Ga-DOTA peptides PET-CT. Apparent diffusion coefficient (ADC) was calculated on target lesions. Results: 426 LMs were analyzed from 17 patients (11 males, mean age 57.2 ± 12.6 years) meeting the inclusion criteria (11.8% G1, 64.7% G2, and 23.5% G3); MRI detected a median of 15 (IQR 2.5-40) lesions per patient, DWI 15 (IQR 2.5-36.5) lesions, while PET-CT 6 (IQR 2.5-20) lesions. Non-parametric analyses suggested that DWI had a detection rate comparable to MRI (p = 0.068) and superior to 68Ga-DOTA peptides PET-CT (p = 0.004), whereas mixed-effects modelling accounting for within-patient clustering showed no statistically significant pairwise differences between imaging modalities after multiple-comparison correction. Moderate-to-good consistency in lesion burden estimation across imaging modalities supported the reproducibility of lesion quantification. Correlation analyses suggested MRI lesion load may reflect the aggressiveness of disease. Conclusions: DWI-MRI can be a useful time-saving imaging technique in the diagnosis and follow-up of LMs from NETs, with a potentially favorable cost-effectiveness ratio.
Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force / Feola, T., Sesti, F., Filice, A., Nistor, A., Valenti, A., Puliani, G., Centello, R., Pandozzi, C., Gagliardi, A., Pirisino, R., Bagni, O., Salducci, M., Appetecchia, M., Catalano, C., Isidori, A.M., Maccioni, F., Giannetta, E.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - 49:(2026), pp. 2759-2768. [10.1007/s40618-026-02974-5]
Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force
Tiziana FeolaPrimo
;Franz SestiSecondo
;Alessia Filice;Alexandra Nistor;Alessandra Valenti;Giulia Puliani;Roberta Centello;Carla Pandozzi;Arianna Gagliardi;Mauro Salducci;Carlo Catalano;Andrea M. Isidori;Francesca MaccioniPenultimo
;Elisa Giannetta
Ultimo
2026
Abstract
Background: A combination of morphological and functional imaging plays a crucial role for neuroendocrine tumors (NETs) management. Diffusion-weighted magnetic resonance imaging (DWI-MRI) is an emerging key imaging technique in the NET field. Aim: to evaluate the diagnostic and prognostic role of DWI-MRI in liver metastases (LMs) from NETs compared with multiparametric MRI and functional imaging with 68Ga-DOTA peptides positron emission tomography (PET)-computed tomography (CT). Methods: This is a monocentric, observational, both retrospective and prospective study including patients with histologically proven diagnosis of gastroenteropancreatic (GEP) NET with LM evaluated with MRI and 68Ga-DOTA peptides PET-CT, performed within 6 months apart at diagnosis or follow-up. We collected clinical, pathological, imaging data including lesions number detected on (a)MRI-gold standard, (b)DWI images, (c)68Ga-DOTA peptides PET-CT. Apparent diffusion coefficient (ADC) was calculated on target lesions. Results: 426 LMs were analyzed from 17 patients (11 males, mean age 57.2 ± 12.6 years) meeting the inclusion criteria (11.8% G1, 64.7% G2, and 23.5% G3); MRI detected a median of 15 (IQR 2.5-40) lesions per patient, DWI 15 (IQR 2.5-36.5) lesions, while PET-CT 6 (IQR 2.5-20) lesions. Non-parametric analyses suggested that DWI had a detection rate comparable to MRI (p = 0.068) and superior to 68Ga-DOTA peptides PET-CT (p = 0.004), whereas mixed-effects modelling accounting for within-patient clustering showed no statistically significant pairwise differences between imaging modalities after multiple-comparison correction. Moderate-to-good consistency in lesion burden estimation across imaging modalities supported the reproducibility of lesion quantification. Correlation analyses suggested MRI lesion load may reflect the aggressiveness of disease. Conclusions: DWI-MRI can be a useful time-saving imaging technique in the diagnosis and follow-up of LMs from NETs, with a potentially favorable cost-effectiveness ratio.| File | Dimensione | Formato | |
|---|---|---|---|
|
Feola_Diffusion-weighted magnetic_2026.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.19 MB
Formato
Adobe PDF
|
1.19 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


